A Closer Look at Pfizer's Options Market Dynamics
Portfolio Pulse from Benzinga Insights
Significant investors have taken a predominantly bearish stance on Pfizer (NYSE:PFE) as observed through unusual options trading activity. The sentiment is split with 25% bullish and 56% bearish trades. The trading activity suggests a price range of $15.0 to $34.0 for Pfizer over the next three months. The stock is currently neutral with an RSI indicator and is trading at $27.4. Analysts have set an average target price of $45.0.
June 27, 2024 | 6:19 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Significant investors have taken a predominantly bearish stance on Pfizer (NYSE:PFE) as observed through unusual options trading activity. The sentiment is split with 25% bullish and 56% bearish trades. The trading activity suggests a price range of $15.0 to $34.0 for Pfizer over the next three months. The stock is currently neutral with an RSI indicator and is trading at $27.4. Analysts have set an average target price of $45.0.
The unusual options trading activity, with a majority of bearish trades, indicates that significant investors expect a decline in Pfizer's stock price. This sentiment is further supported by the current neutral RSI indicator and the stock's slight decline in price. Analysts' target price of $45.0 suggests potential for future growth, but the short-term outlook appears bearish.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100